Effect of treating chronic hepatitis C with direct-acting antivirals on extrahepatic cutaneous manifestations

BACKGROUND: Hepatitis C virus (HCV) is a disease with a significant global impact, affecting approximately 2%-2.5% of the world’s population. New direct-acting antivirals (DAAs) have been introduced over the past few years with great success in viral eradication. The association of chronic HCV infec...

Descripción completa

Detalles Bibliográficos
Autores principales: El Kassas, Mohamed, Hegazy, Osama MO, Salah, Eman M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Observational Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643207/
https://www.ncbi.nlm.nih.gov/pubmed/33200021
http://dx.doi.org/10.4254/wjh.v12.i10.841

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643207/
https://www.ncbi.nlm.nih.gov/pubmed/33200021
http://dx.doi.org/10.4254/wjh.v12.i10.841

Ejemplares similares